Abstract-Aldosteronism eventuates in a proinflammatory/fibrogenic vascular phenotype of the heart and systemic organs.
I
rrespective of its etiologic origins, asymptomatic ventricular systolic dysfunction eventuates in an activation of the circulating renin-angiotensin-aldosterone system (RAAS), whose effector hormones contribute to the appearance of the congestive heart failure (CHF) syndrome. A chronic systemic illness ensues that features oxidative/nitrosative stress in such diverse tissues as skeletal muscle, peripheral blood mononuclear cells (PBMCs) (monocytes and lymphocytes), and heart [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] ; elevated circulating levels of proinflammatory cytokines and chemokines [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] ; and a wasting syndrome that eventuates in cachexia. 22 Pharmacological modulation of RAAS effector hormones has proven clinical benefits in patients with CHF. [23] [24] [25] [26] [27] A role for angiotensin (Ang) II and aldosterone (ALDO) in the pathogenesis of the systemic illness that accompanies CHF is an area of ongoing research. A rodent model has been used to address the consequences of chronic inappropriate (relative to dietary Na ϩ intake) elevations in plasma ALDO comparable to those seen in human CHF. Treatment with ALDO and 1% dietary NaCl (ALDOST) rapidly suppresses plasma renin and Ang II. 28, 29 After 4 weeks of treatment with ALDOST, coronary vascular lesions are first seen in the normotensive, nonhypertrophied right atrium and ventricle and left atrium as well as in the hypertensive, hypertrophied left ventricle. 30 Chronic mineralocorticoid excess, in combination with dietary salt excess and independent of blood pressure, is also known to adversely affect the structure of intramural arteries of systemic organs, including kidneys, pancreas, and mesentery, which can be prevented by ALDOreceptor antagonist. [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] Commonly featured in coronary vascular lesions are inflammatory cells and myofibroblasts. 28, 30, 41 In the monocytes/ macrophages and lymphocytes that invade intramural coronary arteries, Sun et al 42 found an induction of oxidative/ nitrosative stress and activation of a redox-sensitive nuclear transcription factor-B (NF-B), together with upregulated mRNA expression of a proinflammatory mediator cascade that NF-B regulates. Cotreatment with either spironolactone (Spi), an ALDO receptor antagonist, or an antioxidant prevented these molecular events. Eplerenone, another ALDO receptor antagonist, is also cardioprotective in this model. 43 This proinflammatory/fibrogenic cardiac phenotype is not seen with ALDO plus a 0.4% NaCl diet or with a 1% NaCl diet alone. 44 Moreover, cardioprotective effects of ALDO receptor antagonism during ALDOST are seen with either nondepressor or depressor doses of Spi. 45 The importance of ALDOST (vis-a-vis hemodynamic factors) in eliciting this phenotype has been demonstrated in multiple studies reported over the last decade. 28, 38, 39, 41, 42, [45] [46] [47] [48] Nevertheless, there are many gaps in our knowledge regarding the role of ALDO and Na ϩ in the pathogenesis of coronary vascular remodeling, including questions of whether immune cells are activated before tissue invasion and what accounts for the induction of oxidative/nitrosative stress in these cells. Given that Spi abrogates these immune cell responses, as recently reported, 42 whether its mechanism of action is immodulatory remains to be determined.
An Na ϩ -dependent reduction in cytosolic free Mg 2ϩ ([Mg 2ϩ ] i ) accompanies ALDO receptor-ligand binding in cultured human lymphocytes. 49, 50 Herein we hypothesized ALDOST leads to a reduction in PBMC [Mg 2ϩ ] i , the biologically active component of this important intracellular divalent cation, which, in turn, contributes to intracellular Ca 2ϩ loading, the induction of oxidative/nitrosative stress, and immune cell activation before the appearance of the proinflammatory coronary vascular phenotype. We additionally hypothesized that Spi prevents these responses. Accordingly, blood was harvested weekly from uninephrectomized rats receiving ALDOST or ALDOST plus Spi for 4 weeks. We monitored PBMC [Mg 2ϩ ] i and [Ca 2ϩ ] i and several indices of oxidative/nitrosative stress, which included hydrogen peroxide (H 2 O 2 ) generation by PBMCs, differential expression of PBMC genes, including those related to oxidative/nitrosative stress and antioxidant defenses, and circulating B and T lymphocyte responses. At week 4, we examined coronal sections of right and left ventricles for the presence of 3-nitrotyrosine in inflammatory cells that invaded the coronary vasculature. Age-and gender-matched unoperated/untreated and uninephrectomized rats receiving a 1% NaCl diet served as control groups.
Materials and Methods

Animals
Eight-week-old male Sprague-Dawley rats (Harlan, Indianapolis, Ind) were used. The study was approved by the institution's Animal Care and Use Committee. Unoperated, untreated age-and gendermatched rats served as one control group (nϭ5). Uninephrectomized rats receiving 1% NaCl/0.4% KCl in drinking water and standard laboratory chow served as a second control group (nϭ10). Separate groups of uninephrectomized, salt-treated rats received ALDO (0.75 g/h) by implanted minipump (Alzet) for 1 to 4 weeks (nϭ10 at each time point). This dose of ALDO promptly raises the plasma levels in rats to those seen in humans with CHF. ALDOST rapidly suppresses plasma renin activity and circulating angiotensin II. 28, 29 A separate group of animals received ALDOST together with Spi (100 mg/kg by daily gavage). Animals were observed daily for their physical activity and consumption of food and water. Systolic blood pressure was recorded weekly as previously reported. 28, 42 At the conclusion of weeks 1 to 4 of ALDOST and ALDOSTϩSpi, animals were weighed and anesthetized, blood was collected by cardiac puncture, and hearts were harvested. 
Plasma and Cardiac
Isolation of PBMCs
Heparinized whole blood (5 to 8 mL) was diluted to 10 mL with PBS (pH 7.4), layered on top of 5 mL Histopaque 1083, and centrifuged for 30 minutes at 400g. PBMCs were aspirated, washed twice, suspended in PBS, and counted with a hemocytometer.
Quantitation of Total Mg
2؉ and Ca
2؉
Concentration in PBMCs
Isolated PBMCs were washed three times with 140 mmol/L choline chloride. The PBMCs were then lysed with 2 mL deionized water and subjected to three cycles of alternate freezing at Ϫ70°C and thawing. An aliquot of 1.9 mL of isolated PBMC suspension containing 1 to 5 mg/mL protein was digested with 0.4 mL of 0.75 mol/L Ultrex quality nitric acid (J.T. Baker) for 24 hours at 68°C. The acid-extracted suspension was centrifuged, 1 mL of supernatant was diluted with 3 mL 0.5% LaCl 3 solution, and the diluent was used to quantitate PBMC Mg 2ϩ and Ca 2ϩ levels by atomic absorption spectroscopy, as described elsewhere. 52, 53 The protein level in the PBMC suspension was assayed as previously described, 54 55 and an online data supplement is available at http://www.circresaha.org.
Hydrogen Peroxide Generation by PBMCs
For the measurement of hydrogen peroxide (H 2 O 2 ) production, 100-L aliquots of whole blood obtained serially from the same animals by cardiac punction were incubated with 2,7-dichlorofluorescein diacetate (25 mol/L) for 45 minutes at 37°C. After lysing erythrocytes with FACS lysing solution (Becton Dickinson), leukocytes were washed twice and suspended in PBS (pH 7.4). Lymphocyte and monocyte H 2 O 2 production was measured using a FACS Caliber flow cytometer (Becton Dickinson) according to the method of Bass et al. 56 For specific details, see the online data supplement.
PBMC Transcriptome
Total RNA was isolated from purified PBMC using a trireagent (Invitrogen). The gene expression analysis was conducted as previously described 55, 57 using the Affymetrix rat genome U34A chip (Affymetrix), probing Ϸ7000 known genes and 1000 expressed sequence tags. A total of six unoperated/untreated controls, six ALDOST obtained at each time point, and six ALDOSTϩSpi obtained at each time point went into the characterization of transcriptomes. Each sample analyzed on expression array chips consisted of pooled RNA from three animals. We compared transcriptomes from untreated controls with samples obtained at weeks 1 through 4 of ALDOST to produce a list of genes affected by the treatment. The experiment was repeated, and only genes that showed differential expression (Ն2-fold) in response to treatment in both of these independent experiments are reported as differentially expressed genes.
Multicolor Flow Cytometric Analysis of Lymphocyte Activation
Heparinized blood was obtained by cardiac puncture, and PBMCs were isolated by density-gradient centrifugation over Histopaque 1077 (Sigma). PBMCs were counted, washed twice, and resuspended in Dulbecco's PBS (Invitrogen Corporation) supplemented with 2% FCS. For cell-surface labeling, PBMCs (9ϫ10 5 /sample) were incubated with a cocktail of FITC-labeled, PE-labeled, PercPlabeled, and APC-labeled antibodies at 4°C for 20 minutes, washed, and resuspended in PBS-2% FCS. The mouse anti-rat mAbs used for flow cytometry in this study were as follows: FITC-conjugated G4.18 (anti-CD3) and OX-33 (anti-CD45RA), PE-conjugated OX-18 (anti-major histocompatibility [MHC] class I/RT1-A), PercPconjugated OX-8 (anti-CD8) and OX-6 (anti-MHC class II/RT1-B), and APC-conjugated 1F4 (anti-CD3) and OX-35 (anti-CD4) (all from BD Biosciences, San Jose, Calif). Parallel samples of cells were also incubated with Ig isotypic controls (BD Biosciences). Optimal antibody dilutions were determined in preliminary experiments. All samples were immediately analyzed on a FACS Caliber flow cytometer (Becton Dickinson). Fluorescence data from at least 30 000 cells (from a lymphocyte gate) were collected for each sample. Offline analyses of raw data were performed using WinMDI software (J. Trotter, Scripps Institute).
3-Nitrotyrosine in Invading Inflammatory Cells
Expression of oxidative/nitrosative stress was studied by immunohistochemical localization of 3-nitrotyrosine. Lymphocytes and macrophages were detected by immunohistochemical assessment using CD4 and ED-1, respectively. Coronal cryostat sections (6 m) were prepared, air-dried, fixed in 10% buffered formalin for 5 minutes, and washed in PBS for 10 minutes. Sections were then incubated with primary antibody against 3-nitrotyroxine at a dilution of 1:100 (Upstate Biotech, Waltham, Mass) or CD4 at a dilution of 1:50 (Becton Dickinson) or ED-1 at a dilution of 1:140 (Harlan Bioproducts) in PBS containing 1% BSA for 60 minutes. Sections were then washed in PBS for 10 minutes and incubated with IgG peroxidaseconjugated secondary antibody (Sigma) with a dilution of 1:150, washed in PBS for 10 minutes, incubated with 0.5 mg/mL diaminobenzidine tetrahydrochloride 2-hydrate plus 0.05% H 2 O 2 for 10 minutes, and rewashed in PBS. Negative control sections were incubated with secondary antibody alone, stained with hematoxylin, dehydrated, mounted, and examined by light microscopy. An expanded Materials and Methods section can be found in the online data supplement, available at http://www.circresaha.org.
Statistics
Results
Animals
During weeks 1 and 2 of ALDOST treatment, 9-and 10-week-old rats were active, eating, and drinking. They were also gaining weight comparable to age-and gender-matched controls ( Figure 1 ). Rats receiving ALDOST plus Spi cotreatment for weeks 1 and 2 were also healthy, and their body weight was no different from controls ( Figure 1 ). This preclinical stage was followed by the appearance of lethargy and anorexia during weeks 3 and 4 of ALDOST. During this clinical stage, rats failed to gain weight, and their body weight was no longer comparable to controls ( Figure 1 ). On the other hand, animals receiving Spi cotreatment remained healthy, active, and gained weight similar to that observed in both control groups ( Figure 1 ).
Systolic blood pressure at week 1 ALDOST was no different from unoperated/untreated and uninephrectomized/ salt-treated control groups but rose gradually thereafter and was significantly greater (PϽ0.05) than controls at weeks 3 and 4 (Table) . Cotreatment with Spi prevented the gradual rise in blood pressure, with animals remaining normotensive throughout the 4-week period of observation (Table) . Body weight for age-and gender-matched controls and that monitored weekly over 4 weeks in uninephrectomized rats receiving aldosterone plus a 1% NaCl diet (ALDOST) and ALDOST plus Spi (ALDOϩSpi). Spi cotreatment prevented the failure to gain weight seen with ALDOST at weeks 3 and 4. *PϽ0.05 vs controls; meanϮSEM. (Figure 2, left) .
Weekly Blood Pressure in Controls and in ALDOST and ALDO؉Spi Groups
At week 1 of ALDOST, PBMC [Ca 2ϩ ] i was unchanged from controls but rose progressively thereafter and was greater than both control groups at weeks 2, 3, and 4 ( 
Hydrogen Peroxide Generation by PBMCs
At week 1 of ALDOST, H 2 O 2 generation was no different from baseline levels before uninephrectomy and to initiating ALDOST (Figure 3 
PBMC Transcriptome
For the analysis of PBMC-expressed genes, ie, their transcriptome, three pooled blood samples were obtained from nine controls, whereas those harvested weekly from rats receiving either ALDOST or cotreatment with Spi were harvested from 24 rats per treatment group with six rats at each time point per group. Gene chip array analysis was interrogated and compared for the differential (Ն2-fold) expression (either upregulated or downregulated) of genes related to shifts in intracellular monovalent and divalent cations, Na ϩ , Mg 2ϩ , and Ca 2ϩ , the presence of oxidative/ nitrosative stress, and PBMC activation and phenotype.
Relevant to the decline in PBMC [Mg 2ϩ ] i seen during week 1 of the preclinical stage of ALDOST, which was presumably accompanied by Na ϩ loading (not measured), we found upregulated gene expression of an ATPase inhibitor protein (Figure 4 , top left) and an Na ϩ -dependent transporter ( Figure  4 , bottom left), which was sustained over 4 weeks. Spi cotreatment attenuated these responses. Other upregulated PBMC genes seen during this time frame with ALDOST (not shown) included somatostatin receptor and Na ϩ -dependent serotonin transporter, whereas the ␣ 1 isoform of Na ϩ /K ϩ -ATPase was downregulated. Spi cotreatment served to attenuate these responses at all time points. We did not find specific genes that only became markedly (Ͼ2-fold) upregulated or downregulated at weeks 3 or 4 of ALDOST treatment or that responded in a like manner to Spi cotreatment at these time points.
Intracellular Ca 2ϩ loading, initially of organelles, and subsequently free ionized cytosolic levels appeared during the preclinical stage of ALDOST and were associated with upregulated expression of an ATP-dependent Ca 2ϩ pump (Figure 4 , top right) and calmodulin kinase, a Ca 2ϩ -dependent protein kinase C-associated kinase (Figure 4, bottom binding protein but did not alter these other responses at any time point. We did not find specific genes that were first markedly upregulated or downregulated at weeks 3 or 4 of ALDOST or that were similarly altered by Spi cotreatment.
The presence of oxidative/nitrosative stress in PBMCs throughout 4 weeks of ALDOST treatment was evidenced by responses in their transcriptome. This included an early, upregulated expression of oxidative stress-inducible tyrosine phosphatase (not shown) and such antioxidant defenses as Mn 2ϩ -superoxide dismutase and L-cysteine oxireductase (Figure 5, top and bottom) . Inducible NO synthase was also upregulated (not shown) and is integral to NO formation that regulates the mitochondrial electron transport chain, a major source of reactive oxygen species. Glutathione peroxidase 
Lymphocyte Activation
Our transcriptome data suggested ALDOST treatment is accompanied by B-cell activation (eg, increased immunoglobulin gene transcription). At week 4, we determined the B/T cell ratio in control, ALDOST, and Spi cotreated rats by flow cytometry (Figure 7 ) and found a relative expansion of the B lymphocyte subset in ALDOST rats compared with UN controls and that was attenuated by Spi. Moreover, MHC class II-expressing lymphocytes were increased in ALDOST rats at week 4, consistent with the upregulation of MHC II genes. The increase in MHC class II-positive cells is also in keeping with the immune activation induced by ALDOST. Indeed, by multicolor flow cytometry, we confirmed that the B-cell subset is the major class II-expressing population of lymphocytes. Within the CD3 ϩ T-cell population, we did not detect differences in the CD4/CD8 ratio among the various treatment groups (data not shown).
3-Nitrotyrosine in Immune Cells Invading the Coronary Vasculature
As reported previously, 41, 42 the proinflammatory coronary vascular phenotype first appears at week 4 of ALDOST treatment. Peroxynitrite (OONO Ϫ ) is a potent reactive nitrogen species formed by the reaction of NO and superoxide. Its short half-life makes detection of OONO Ϫ difficult. However, its reaction with stable tyrosine residues forms a stable 3-nitrotyrosine derivative and serves as a marker of nitrosative stress. Immunohistochemical evidence of 3-nitrotyrosine was found in inflammatory cells, including CD4 ϩ lymphocytes, that invaded the coronary vasculature of the right and left heart at week 4 of ALDOST ( Figures 8A and 8C) . ED-1-positive macrophages were also found to have 3-nitrotyrosine labeling (not shown). Cotreatment with Spi prevented the appearance of 3-nitrotyrosine labeling in cells that invaded intramural coronary arteries (Figures 8B) and attenuated the number of inflammatory cells seen at these sites.
Discussion
Herein we hypothesized that chronic treatment with ALDO and 1% dietary NaCl leads to an iteration in PBMC divalent cation composition, which, in turn, accounts for an induction of oxidative/nitrosative stress and activation of these immune cells that subsequently invade the intramural coronary vasculature of the right and left heart. We additionally hypothesized that by abrogating these responses in PBMC divalent cations, Spi would be immunomodulatory. Our study led to several major findings.
Beginning with the preclinical stage of ALDOST, we found a reduction in PBMC [Mg 2ϩ ] i that was significantly lower than levels found in PBMCs obtained from either of our two control groups or historical controls reported by others. 58 65 We cannot implicate dietary Mg 2ϩ deficiency, given that the Mg 2ϩ content of our standard chow (20 to 40 mmol/kg) is in keeping with daily requirements and far greater than that (Ͻ2 mmol/kg) needed to induce dietary Mg 2ϩ deficiency. 66, 67 Future studies are planned to address responsible mechanisms. Mg 2ϩ is involved in Ͼ300 enzymatic reactions, including Mg 2ϩ -dependent Na ϩ /K ϩ -ATPase. 59, 61 A reduction in the activity of this exchanger leads to a rise in intracellular Na ϩ followed by the stoichiometric exchange of 3 Na ϩ for 1 Ca 2ϩ via a Na ϩ /Ca 2ϩ exchanger. 68, 69 At week 1 of ALDOST treatment, analysis of PBMC transcriptome revealed upregu- lated expression of an ATPase inhibitor protein and Na ϩ -dependent transporter, together with a downregulation in ␣ 1 isoform of Na ϩ /K ϩ -ATPase and upregulation in ATPdependent Ca 2ϩ pump, each of which persisted during subsequent weeks of ALDOST treatment. Spi attenuated these responses. Total intracellular Ca 2ϩ was increased throughout the 4-week period of ALDOST and is likely responsible for the early and persistent induction of oxidative/nitrosative stress. PBMC [Ca 2ϩ ] i rose at weeks 2 through 4 of ALDOST treatment, in keeping with the saturation of organella stores during week 1. ALDO and extracellular Na ϩ are each known to upregulate Ca 2ϩ uptake in various cells, including lymphocytes. 70, 71 Furthermore, ALDO reversibly downregulates the activity of a Na ϩ /Ca 2ϩ exchanger, which would inhibit net Ca 2ϩ efflux from PBMCs. 72, 73 Collectively, these responses would account for intracellular Ca 2ϩ loading, which we observed for both cytosolic free [Ca 2ϩ ] i and total Ca 2ϩ concentration of PBMCs. In both humans and experimental animals, chronic mineralocorticoid excess, derived from either endogenous or exogenous sources and inappropriate for dietary Na ϩ , is associated with a rise in platelet [Ca 2ϩ ] i and release of endogenous, circulating ouabain, a Na ϩ /K ϩ -ATPase inhibitor, which normalized after surgical ablation. 74 -78 Na ϩ -Ca 2ϩ exchange is dependent on cell Na ϩ and is competitively inhibited by Mg 2ϩ . 79 A 4-g NaCl diet in a black population with salt-sensitive hypertension is accompanied by increases in erythrocyte Ca 2ϩ and Na ϩ concentrations and Ca 2ϩ -ATPase activity, whereas [Mg 2ϩ ] i and Na ϩ /K ϩ -ATPase activity are each reduced. 80 Spi cotreatment in our rodent model of ALDOST prevented the rise in [Ca 2ϩ ] i that appeared at weeks 2 through 4 of ALDOST treatment, suggesting that it altered Na ϩ delivery to and Na ϩ /Ca 2ϩ exchange in PBMCs. 81 71 Nifedipine, a dihydropteridine Ca 2ϩ entry blocker, prevents renovascular lesions that accompany chronic mineralocorticoid excess. 82 Thus, our findings implicate Na ϩ -dependent intracellular Ca 2ϩ loading as integral to other events that appeared in PBMCs during ALDOST. Increased [Ca 2ϩ ] i is an intracellular messenger integral to lymphocyte activation that appears in response to antigen-binding and antigen-presenting cells. 83 It has been reported to play a major regulatory role in the generation of reactive oxygen species in chemotactic factor-stimulated neutrophils. 81 Concordant with the rise in intracellular Ca 2ϩ was the induction of oxidative/nitrosative stress in PBMCs, as indicated by several lines of evidence. PBMC transcriptome at 1 to 4 weeks of ALDOST treatment revealed overexpression of oxidative stress-inducible tyrosine phosphatase and upregulation of enzymes associated with antioxidant defense systems, such as Mn 2ϩ -superoxide dismutase (SOD), L-cysteine, and NADPH oxireductases, and inducible NO synthase. In monocytes and lymphocytes obtained from rats receiving ALDOST at 2 to 4 weeks, we found evidence of increased H 2 O 2 production, suggesting antioxidant defenses in these cells were no longer able to neutralize this stress, as presumably had been the case at week 1. Persistent oxidative/ nitrosative stress may have contributed to the appearance of the systemic illness and catabolic state seen in these rats at weeks 3 through 4 of ALDOST, which featured lethargy, anorexia, and a failure to gain weight. In preventing oxidative/nitrosative stress, Spi cotreatment prevented this clinical response. At week 4 of ALDOST treatment, we found immunohistochemical localization of 3-nitrotyrosine in inflammatory cells that invaded intramural coronary arteries. Sun et al 42 have previously reported the presence of oxidative/nitrosative stress in these immune cells that first invade the coronary circulation at 4 weeks of ALDOST treatment. This included activation of gp91 phox , a membrane-bound NADPH oxidase subunit, and the RelA subunit of a redoxsensitive NF-B, together with a proinflammatory mediator cascade it regulates. This cascade included upregulated mRNA expression of ICAM-1, monocyte chemoattractant protein (MCP)-1, and tumor necrosis factor (TNF)-␣. These cellular and molecular events were not seen when ALDOST was combined with either an antioxidant or Spi. Herein, we report the prevention of the rise in PBMC [Ca 2ϩ ] i by Spi cotreatment, and this negated the induction of oxidative/ nitrosative stress in these immune cells that invade the coronary vasculature.
A third finding of our study was the activation of PBMCs before the appearance of the proinflammatory coronary vascular phenotype seen at week 4 of ALDOST treatment. This occurred in the absence of myocardium-derived antigen, given that the heart in our rat model is intact and free of prior injury. This early immunostimulatory state included (1) B-cell activation with increased expression of immunoglobulins; (2) an expansion of the B-cell lymphocyte subset; (3) an increase in MHC class II-expressing lymphocytes; (4) increased expression of ICAM-1, integrin ␣ 1 , CC chemokine receptor protein and receptor CCR 2 , CXC chemokine receptor, IL-1␤, its receptor type 2, and accessory protein; and (5) inducible interferon-␥. There was also evidence to implicate autoreactivity with increased expression of antibodies to acetylcholine receptors and nerve growth factor and reduced RT-6.2. RT-6, an alloantigenic marker of mature resting T cells, is lost on activation. Cytotoxic T cells do not display RT-6 and are associated with autoimmunity. 84 -87 RT-6 exists in at least two allelic forms, RT-6.1 and RT-6.2, where RT-6.2 consists of a nonglycosylated 25-and 28-kDa form. 88 Circulating levels of CC chemokines, including MCP-1, macrophage inflammatory protein (MIP)-1␣, and RANTES (Regulated on Activation Normally T Cell Expressed and Secreted), are increased particularly in patients with advanced, symptomatic failure at rest (NYHA class IV) irrespective of its etiologic origins. 16 Monocytes and CD3 ϩ lymphocytes (T lymphocytes) obtained from individuals with NYHA class III and IV failure have been studied in culture with respect to their release of CC chemokines. 16 In response to stimulation of monocytes with LPS or CD3 ϩ lymphocytes with anti-CD3/anti-CD28 monoclonal antibodies, increased release of MIP-1␣ and MCP-1 was observed for monocytes and increased release of RANTES by CD3 ϩ lymphocytes (vis-a-vis healthy blood donor controls). The effect of serum from these patients on superoxide generation by cultured monocytes harvested from healthy blood donors was also examined. 16 Spontaneous and provoked generation of superoxide was enhanced and to an extent related to serum MCP-1 levels, which could be inhibited by neutralizing antibodies to this CC chemokine. Serum levels of CXC chemokines, including IL-8, growth-regulated oncogene ␣, and epithelial neutrophil activating peptide-78, are also elevated in patients with heart failure and to an extent related to the severity of symptomatic heart failure. 17 Furthermore, spontaneous and LPS-stimulated monocytes from these patients release elevated amounts of these CXC chemokines. 17 Damås et al 18 demonstrated upregulated PBMC gene expression (ribonuclease protection assay) for MIP-1␣, MIP-1␤, IL-8, and their corresponding receptors, which include CCR1 and CCR5, CXC chemokine receptor 1, and CXC chemokine receptor 2 in patients with heart failure of diverse causality. Thus, in humans with symptomatic heart failure, where salt and water retention and elevated plasma levels of ALDO are expected, as well as in our rodent model of ALDOST, there is evidence of sustained monocyte and lymphocyte activation. Such "runaway inflammation" may contribute to the chronic "cytokine storm" seen with the CHF syndrome. An initial immunostimulatory state that begins during week 1 of ALDOST treatment, based on Na ϩ -dependent, ALDO-induced activation of PBMCs, is sustained and begets an immunopathologic state with cardiac lesions at week 4. Dietary-induced Mg 2ϩ deficiency and associated aldosteronism 89, 90 is accompanied by reduced Mg 2ϩ and increased Na ϩ and Ca 2ϩ in lymphocytes, 91 evidence of oxidative/ nitrosative stress in plasma, reduced antioxidant reserves in PBMCs, elevated PBMC proinflammatory cytokine production at week 1, and a delayed appearance in cardiac pathology seen at week 3, 66,67 together with upregulated expression of stress proteins and glutathione transferase in neutrophils and thymocytes. 92, 93 The appearance of exaggerated immune cell responses seen with Mg 2ϩ deficiency includes superoxide anion production and enhanced [Ca 2ϩ ] i , which have been attributed to abnormal Ca 2ϩ handling. 94 We believe the antigen-independent activation of cellular immunity seen with ALDOST is related to H 2 O 2 production and its role as second messenger. Reth 95 has reviewed the evidence implicating H 2 O 2 as second messenger capable of antigen mimicry. Redox-regulated proteins include transcription factors that can either prevent (p53) or stimulate (p50) their transcriptional activity. Other redox-regulated proteins, which we observed in our analysis of PBMC transcriptome, are the protein tyrosine phosphatases. They are rendered inactive by H 2 O 2 . In lymphocytes, H 2 O 2 can be spontaneously generated from superoxide and protons in water or catalyzed by cytosolic SOD. Another source of superoxide is NADPH oxidase/reductase. In response to ALDOST, we found upregulated expression of both SOD and NADPH oxidase/ reductase in PBMC transcriptome. Sun et al 42 found immunohistochemical evidence that the gp91 phox subunit of NADPH oxidase was activated in cells invading the intramural coronary vasculature. NADPH oxidase is pertinent to inducible oxidative/nitrosative stress in lymphocytes during signal transduction. 96 Lymphocytes produce H 2 O 2 on stimulation of their antigen receptor, whereas immunoglobulins (or antibodies) do not require a particular antigen binding site to incite H 2 O 2 production. [97] [98] [99] Receptors can be activated in a ligand-independent manner when immune cells are treated with H 2 O 2 . B-cell activation leads to antibody production. In patients with heart failure of diverse origins, circulating antibodies to muscarinic M 2 -acetylcholine receptors (AchR) have been observed and correlated with the severity of their symptomatic status. 100 -104 Specific immune responses may be involved in activated PBMCs targeting the intramural coronary vasculature and could explain why cardiac lesions of the right and left heart are not seen until week 4 of ALDOST treatment. Adoptive transfer studies have been planned to address the issues concerning an autoimmune response. However, the need for coronary endothelial cell activation in contributing to this response remains uncertain.
Findings of this study relate to the pathophysiology of chronic cardiac failure in humans, where an activation of the circulating RAAS is accompanied by a progressive systemic illness that features oxidative/nitrosative stress, lethargy, and a catabolic state with wasting. Herein, we found ALDOST in rodents to lead to an early activation of PBMCs before the appearance of lethargy, anorexia, failure to gain weight, and coronary lesions. The prospect of B-cell activation and autoreactivity in the absence of antigen presentation calls into question their potential for autoimmune-mediated injury that targets the intramural vasculature and leads to a progressive structural remodeling of involved vessels. Functional consequences of antibody interference with AchR seen with ALDOST may include a modulation of parasympathetic control of heart rate and conduction, 105 reduced baroreceptor discharge, 106 impaired vasodilator reserve to Ach, 40, 107 and nerve growth factor that maintains the integrity of sympathetic innervation. 108 Our observations broaden the paradigm embraced by the concept of a neuroendocrine-immune interface. 109, 110 In summary, findings of this study have addressed several gaps in our knowledge. In aldosteronism, PBMCs are activated before invading the intramural coronary arterial circulation. Activation of these immune cells by intracellular Ca 2ϩ loading leads to the induction of oxidative/nitrosative stress, including H 2 O 2 production, which likely serves as second messenger to mimic antigen-receptor binding and lymphocyte activation. The clinical efficacy of ALDO receptor antagonism in the management of symptomatic heart failure, 26, 27 where aldosteronism is expected, may include its ability to modulate this neuroendocrine-immune interface.
